Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ALLI
Active substances:
Estonian, English, Latin
ATC code: A08AB01
Dosage form: capsule, hard
Strength: 60mg
Legal status for supply*: Not subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: alli is indicated for weight loss in adults who are overweight (body mass index, BMI, >_28 kg/m2) and should be taken in conjunction with a mildly hypocaloric, lower-fat diet.
Safety features: No
Marketing authorization holder: GlaxoSmithKline Dungarvan Limited 
Marketing authorization number: EU/1/07/401 
Marketing authorization issued on: July 25, 2012 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1395301  ALLI  capsule, hard  60mg 42TK  OTC      03.06.2010     
1395356  ALLI  capsule, hard  60mg 60TK  OTC           
1395367  ALLI  capsule, hard  60mg 84TK  OTC      09.12.2011     
1395378  ALLI  capsule, hard  60mg 90TK  OTC           
1489709  ALLI  capsule, hard  60mg 120TK  OTC           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere